Delivering the Goods

The Bio Report

Nearly 70 percent of patients with chronic conditions fail to take their medicines as prescribed. This can lead to poor outcomes and greater healthcare costs. Vivani Medical, which has developed implantable drug delivery technology, said it can provide steady drug release for up to six months with a single implant. This not only can address the problem of non-compliance, but can also reduce side effects associated with fluctuating drug release from conventional delivery methods. We spoke to Adam Mendelsohn, CEO of Vivani Medical, about its implantable drug delivery technology, how it works, and why its lead indication is a GLP-1 implant for weight loss and diabetes.